Provisional application receives approval through the first international collaborative review initiative between TGA, FDA and HC
Published
Related content
- Acalabrutinib receives TGA approval for CLL and SLL cancersAcalabrutinib receives approval through the second international collaborative review initiative between the TGA, FDA and Health Canada
- International work-sharing Initiative - Niraparib (Zejula®)International work-sharing initiative approves Niraparib (Zejula®)
- International Work-sharing Initiative - Abemaciclib (Verzenio)Second candidate in international work-share initiative